Showing results (621-630 of 864) with videos related to
Sort By:
Pageof 87
Current Drug Discovery Technologies|June 7, 2023
Nanoencapsulation of Ruthenium Complex Ru(ThySMet): A Strategy to Improve Selective Cytotoxicity against Breast Tumor Cells in 2D and 3D Culture ModelsAmanda Blanque Becceneri, Angelina Maria Fuzer, Ana Carolina Lopes, et al.Current Drug Discovery Technologies|May 8, 2026
Design and Evaluation of Semi-Synthetic Morin Derivatives as Promising Antitumor Agents against Breast and Liver CancerNisha Devi, Amarjeet Singh, Jyoti GuptaCurrent Drug Discovery Technologies|September 15, 2010
Nanoemulsion encapsulation and in vitro SLN models of delivery for cytotoxic methotrexateCormac Concannon, Desmond A Hennelly, Simon Noott, et al.Current Drug Discovery Technologies|July 19, 2013
Formulation and evaluation of niosomal nasal drug delivery system of folic acid for brain targetingNagaraju Ravouru, Pallavi Kondreddy, Deepthy Korakanchi, et al.Current Drug Discovery Technologies|June 8, 2023
Automating Drug Discovery using Machine LearningAli K Abdul Raheem, Ban N DhannoonCurrent Drug Discovery Technologies|July 3, 2026
Discovery of Phytochemicals as Inhibitors of Human Metapneumovirus: In-Silico Docking StudiesVeerachamy Alagarsamy, Mohaideen Thasthagir Sulthana, Viswas Raja Solomon, et al.Current Drug Discovery Technologies|February 21, 2012
Exploiting metabolic differences in glioma therapyFrancesca Galeffi, Dennis A TurnerCurrent Drug Discovery Technologies|June 15, 2022
Synthesis and Biological Evaluation of Some New Chalcone Derivatives as Anti-inflammatory AgentsZia Ur Rehman, Pooja Saini, Sushil KumarCurrent Drug Discovery Technologies|February 5, 2011
Silica materials in drug delivery applicationsSpomenka Simovic, Nasrin Ghouchi-Eskandar, Aw Moom Sinn, et al.Current Drug Discovery Technologies|February 5, 2011
20 years of lipid nanoparticles (SLN and NLC): present state of development and industrial applicationsRainer H Müller, Ranjita Shegokar, Cornelia M KeckPageof 87